Image Source: American Heart Association Journals The California Institute for Regenerative Medicine (CIRM) awarded $4 million to support a gene therapy for rare life-threatening genetic disorder. A rare heart disorder Known as desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM), the genetic disorder is a rare heart disorder. This preclinical award went to Deborah D. Ascheim, … Continue reading CIRM Supports Innovative Gene Therapy for Rare Heart Disorder
Genetic disorder
Gene-editing Technique in Mice Shows Promise for Genetic Disorder in Utero
For first time ever, scientists used a gene editing technique to successfully cure a genetic condition in a mouse in utero. Their findings present a promising new avenue for research into treating genetic conditions in utero.